Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

AGM Statement

16 Jun 2009 07:00

Embargoed Release: 07:00hrs Tuesday 16 June 2009

SOPHEON PLC AGM Statement

At the Annual General Meeting of Sopheon plc to be held later today, the chairman of the board will give shareholders an update and review of the business. This will include the following statement:

"Sopheon delivered a landmark performance in 2008. We reported revenues of £ 9.3m, a year-over-year increase of 47%. We also showed good improvement in profitability. Since the start of 2009, we have closed a total of 15 new and extension license orders. The total licensee base now stands at 163 and recurring revenues from maintenance, hosting and rental licenses now stand at £ 4 million compared to £2.9 million a year ago. Revenue visibility for the full year from contracted business and recurring revenue streams, now stands at £ 6.2 million. We had expected to report a higher figure to shareholders at this point in time, however, as noted in our Interim Management Statement of 7 May, our performance in current market conditions remains unpredictable. A number of opportunities that we had expected to close in the second quarter are now unlikely to conclude until the third or fourth quarters of the year. Several of these prospects have attributed the delays to more stringent approval processes imposed due to the current market uncertainty.

The majority of the affected prospects remain in active sales cycles, and a number of them are beginning to indicate early signs of improvement in conditions. Accordingly, we continue to expect to close these opportunities in the second half of the year, in addition to new business originally identified for the third and fourth quarters. This will be a major challenge but one we will embrace with vigour. The impact of the economy aside, such delays are not a new experience for Sopheon. We have consistently noted our business dependency on a small number of relatively large deals, any of which can materially impact the revenue recorded in a particular period. While we do anticipate closing further business in June, a possible effect of the ongoing delays is that revenues in the first half of 2009 may be lower than those recorded in the comparable period last year. With higher costs due to higher staff levels (particularly in product development) and the impact of the weakness of Sterling, this is expected to result in an EBITDA loss for the first half of the year. In our announcement of 7 May we noted that while we had expanded investment in product development, we had taken action to reduce and reorganize certain operational groups. The financial benefit of this adjustment will feed through into the second half the year. However, as a prudent measure in these unpredictable times, we are evaluating further cost adjustments, as well as negotiating improved cash facilities.

As we face the current challenges, we are fortified by our recent achievements. Over the last two years we have evolved Sopheon from a single product company to one with a product family of three. This has been accomplished through a combination of strategic investment, partnership activity and an unremitting focus on product development. Our first milestone in this expansion in scope was in 2007 with the acquisition of Alignent Software, bringing its Vision Strategist roadmapping solution into our product set. This was followed last year with the pivotal release of version 7.0 of our core Accolade platform. Most recently, we announced the launch of Idea Lab, our new idea development software, which has expanded the capacity of our solution set to strengthen the front-end of the product innovation process. With this launch, Sopheon now offers the first software suite in the industry to provide all-in-one support that encompasses innovation strategy, ideation and execution. We remain convinced that this represents a highly differentiated value proposition, and are encouraged by strong interest from the market and influential, positive affirmation from the business analyst community."

-Ends-

For further information contact:

Barry Mence, Chairman Sopheon plc + 44 (0) 1483 685 735

Arif Karimjee, CFO Vikki Krause Hansard Communications + 44 (0) 207 245 1100 + 44 (0) 7515 922906 Claire Verhagen Citigate First Financial + 31 (0) 205 754 010 Sarah Jacobs Seymour Pierce + 44 (0) 207 107 8000 About Sopheon

Sopheon is an international provider of software and services that help organisations improve the business impact of product innovation. Sopheon's solutions automate and govern the innovation process, enabling companies to increase revenue and profits from new products. Sopheon's solutions are used by industry leaders throughout the world, including BASF, Cadbury Schweppes, Corning, Electrolux, General Motors, Honeywell, Motorola and SAB Miller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

vendor
Date   Source Headline
10th Jun 20217:00 amRNSAGM Statement
3rd Jun 20211:50 pmRNSIssue of Equity
2nd Jun 20217:00 amRNSSopheon Deployed Globally at The 3M Company
14th May 202110:11 amRNSGrant of Options / PDMR dealing
14th Apr 20217:00 amRNSLaunch of Accolade for Smart Products
9th Apr 20214:15 pmRNSIssue of Equity
31st Mar 20217:00 amRNSDirectorate Change
29th Mar 20212:30 pmRNSDirector Shareholdings
24th Mar 20217:00 amRNSFinal Results
3rd Mar 202111:02 amRNSHolding(s) in Company
2nd Mar 202112:12 pmRNSHolding(s) in Company
26th Feb 20214:20 pmRNSResult of Secondary Placing
26th Feb 20211:36 pmRNSProposed Secondary Placing
8th Feb 20214:30 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSSopheon extend innovation leadership with Simplot
25th Jan 20217:00 amRNSTrading Update
5th Nov 20207:00 amRNSRelease of Accolade version 13.2
12th Oct 20207:00 amRNSSeasoned Cloud & Industry Executive added to Team
9th Sep 20209:55 amRNSOrion Engineered Carbons works with Sopheon
1st Sep 202011:38 amRNSDirector Shareholdings
28th Aug 202012:39 pmRNSIssue of Equity
27th Aug 20207:00 amRNSInterim Results
30th Jul 20207:00 amRNSMondelez Partnership
13th Jul 202011:41 amRNSGrant of Options/PDMR Dealing
11th Jun 202011:28 amRNSResult of AGM
9th Jun 202012:00 pmRNSIssue of Equity & Director/PDMR Shareholding
28th May 20207:29 amRNSProgressive publishes new research
28th May 20207:00 amRNSNew Sopheon Release Integrating Microsoft Teams
15th May 202010:01 amRNSIssue of Equity
15th May 20207:00 amRNSAGM Notice and Update
3rd Apr 202011:17 amRNSDirector Shareholdings
25th Mar 20201:38 pmRNSIssue of Equity
19th Mar 20204:46 pmRNSIssue of Equity
19th Mar 20207:00 amRNSFinal Results
28th Jan 20209:05 amRNSSecond Price Monitoring Extn
28th Jan 20209:00 amRNSPrice Monitoring Extension
28th Jan 20207:00 amRNSTrading Update
10th Jan 20201:00 pmRNSIssue of Equity
11th Dec 20197:00 amRNSTrading Update
10th Oct 201912:00 pmRNSIssue of Equity
1st Oct 201912:00 pmRNSIssue of Equity
20th Sep 20194:45 pmRNSIssue of Equity
22nd Aug 20192:06 pmRNSSecond Price Monitoring Extn
22nd Aug 20192:01 pmRNSPrice Monitoring Extension
22nd Aug 201911:05 amRNSSecond Price Monitoring Extn
22nd Aug 201911:00 amRNSPrice Monitoring Extension
22nd Aug 20199:05 amRNSSecond Price Monitoring Extn
22nd Aug 20199:00 amRNSPrice Monitoring Extension
22nd Aug 20197:00 amRNSHalf-year Report
12th Aug 201910:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.